As per the prior post we are now short on Silgan (SLGN). We will add to the position if the stock goes higher. . www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every
Silgan Holdings (SLGN) has announced that it will acquire Graham Packaging Company (GRM). The acquisition is accretive. Silgan may have to assume quite a bit of debt in this deal . This makes Silgan a very risky stock to hold. As of this writing the stock is at $43.5. The
We are short on Identive Group (INVE). We will be adding to the short position as per the prior post. Our estimate is that the Google order to Identive for Austin is worth about $400.00. It is investor insanity that caused over $144 million increase in the stock capitalization based
As per the prior post, we are now short on Identive Group (INVE) from $5.89. Our position in Identive Group is only 5% of the full position size. For our plans regarding this position, please see the prior posts. www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY
Identive (INVE) scored a coup when it sold its RFID stickers for the roll out of Google’s marketing campaign for Google Places in Austin, TX. These stickers are used to convert conventional posters to smart posters. Consumers with NFC enabled mobile phones, can simply touch their phones to the poster
As per the prior post, we are looking for a pull back to buy Level 3 Communications (LVLT). The computers at The Arora Report are monitoring every tick of trading in Level 3 Communications. We further dissect the data to figure out what smart money is doing. The money flow data so
Yesterday, we wrote in the real time feed of ZYX BUY CHANGE ALERTS : LVLT will acquire GLBC. 16 shares of LVLT will be exchanged for one share of GLBC. Our analysis shows that this acquisition is positive for LVLT and we expect LVLT to trade higher. LVLT is a deep
NXP Semiconductors (NXPI) has been running up on rampant speculation that NXP Semiconductors is for sale. Now the CEO has come out and clearly stated that he is not shopping the company. The CEO also stated that he is looking to acquire another semiconductor company. We trade based on the
The drug from Xenoport (XNPT) is for moderate to severe Restless Leg Syndrome. This drug will compete with existing treatments IT is not clear if the drug presents an advantage compared to the existing treatments with the exception of a small number of patients. It does not appear that the
Investors bid up shares of Xenoport (XNPT) by 56% on approval of Horizant.The company will have difficulty generating profits to support this huge stock move. We are now short from $10.18. For more details of the rationale to short sell, target tzone, stop zone,and real time updates, check out ZYX SHORT SELL CHANGE